{"id":689,"date":"2026-04-27T11:11:32","date_gmt":"2026-04-27T11:11:32","guid":{"rendered":"https:\/\/equitiesorbis.com\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/"},"modified":"2026-06-08T19:09:41","modified_gmt":"2026-06-08T19:09:41","slug":"%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3","status":"publish","type":"post","link":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/","title":{"rendered":"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3"},"content":{"rendered":"\n<p>\u8bfa\u548c\u8bfa\u5fb7 (NYSE: NVO) \u662f\u50ac\u5316\u5168\u7403 GLP-1 \u51cf\u80a5\u9769\u547d\u7684\u4e39\u9ea6\u5236\u836f\u5de8\u5934\uff0c\u5728 2026 \u5e74\u6b63\u5904\u4e8e\u5173\u952e\u65f6\u523b\u3002\u5728\u7ecf\u5386\u4e86\u91cd\u78c5\u836f\u7269 Ozempic \u548c Wegovy \u9a71\u52a8\u7684\u591a\u5e74\u7206\u53d1\u5f0f\u589e\u957f\u540e\uff0c\u8be5\u516c\u53f8\u6b63\u9762\u4e34\u7740\u7ade\u4e89\u52a0\u5267\u3001\u4ef7\u683c\u538b\u529b\u52a0\u5927\u4ee5\u53ca\u4e34\u5e8a\u7814\u53d1\u7ba1\u7ebf\u91cd\u5927\u632b\u6298\u6240\u5b9a\u4e49\u7684\u5feb\u901f\u53d8\u5316\u7684\u683c\u5c40\u3002\u968f\u7740\u80a1\u4ef7\u8dcc\u81f3\u591a\u5e74\u4f4e\u70b9\uff0c\u6295\u8d44\u8005\u5fc5\u987b\u5728\u516c\u53f8\u5f3a\u5927\u7684\u957f\u671f\u6f5c\u529b\u4e0e\u4e25\u5cfb\u7684\u77ed\u671f\u963b\u529b\u4e4b\u95f4\u8fdb\u884c\u6743\u8861\u3002\u672c\u5206\u6790\u63a2\u8ba8\u4e86\u8bfa\u548c\u8bfa\u5fb7\u7684\u57fa\u672c\u9a71\u52a8\u56e0\u7d20\u3001\u7ade\u4e89\u52a8\u6001\u548c\u6295\u8d44\u903b\u8f91\u3002   <\/p>\n\n<h2 class=\"wp-block-heading\">GLP-1 \u4e0e\u80a5\u80d6\u75c7\u836f\u7269\u5e02\u573a<\/h2>\n\n<p>\u5168\u7403\u80f0\u9ad8\u8840\u7cd6\u7d20\u6837\u80bd-1 (GLP-1) \u53d7\u4f53\u6fc0\u52a8\u5242\u5e02\u573a\u4ee5\u60ca\u4eba\u7684\u901f\u5ea6\u6269\u5f20\uff0c\u4ece\u4e00\u79cd\u5c0f\u4f17\u7684\u7cd6\u5c3f\u75c5\u6cbb\u7597\u624b\u6bb5\u6f14\u53d8\u4e3a\u4f53\u91cd\u7ba1\u7406\u7684\u4e3b\u6d41\u73b0\u8c61\u30022025 \u5e74\uff0c\u5168\u7403 GLP-1 \u6fc0\u52a8\u5242\u5e02\u573a\u4ef7\u503c\u7ea6\u4e3a 644 \u4ebf\u7f8e\u5143\uff0c\u9884\u8ba1\u5230 2033 \u5e74\u53ef\u80fd\u98d9\u5347\u81f3 1,700 \u4ebf\u7f8e\u5143\u4ee5\u4e0a\uff0c\u590d\u5408\u5e74\u589e\u957f\u7387 (CAGR) \u4e3a 13% [1]\u3002\u636e\u4f30\u8ba1\uff0c\u4f7f\u7528 GLP-1 \u6cbb\u7597\u7684\u7f8e\u56fd\u4eba\u6570\u53ef\u80fd\u4ece 2025 \u5e74\u7684\u7ea6 1,000 \u4e07\u589e\u52a0\u5230 2030 \u5e74\u7684 3,000 \u4e07\u4ee5\u4e0a [2]\u3002  <\/p>\n\n<p>\u8bfa\u548c\u8bfa\u5fb7\u4e00\u76f4\u662f\u8be5\u9886\u57df\u65e0\u53ef\u4e89\u8bae\u7684\u5148\u9a71\u30022025 \u5e74\uff0c\u8be5\u516c\u53f8\u62a5\u544a\u5168\u7403\u54c1\u724c GLP-1 \u80a5\u80d6\u75c7\u5e02\u573a\u7684\u9500\u91cf\u589e\u957f\u4e86\u60ca\u4eba\u7684 104%\uff0c\u4fdd\u6301\u4e86 59.6% \u7684\u54c1\u724c\u9500\u91cf\u5e02\u573a\u4efd\u989d\u4e3b\u5bfc\u5730\u4f4d [3]\u3002\u5168\u7403\u80a5\u80d6\u75c7\u6d41\u884c\u7684\u5de8\u5927\u89c4\u6a21\u63d0\u4f9b\u4e86\u4e00\u4e2a\u51e0\u4e4e\u65e0\u4e0e\u4f26\u6bd4\u7684\u6f5c\u5728\u5e02\u573a\u603b\u91cf\u3002\u7136\u800c\uff0c\u968f\u7740\u5e02\u573a\u7684\u6269\u5927\uff0c\u4f9b\u9700\u548c\u5b9a\u4ef7\u52a8\u6001\u6b63\u5728\u53d1\u751f\u6df1\u523b\u53d8\u5316\u3002   <\/p>\n\n<h2 class=\"wp-block-heading\">\u7ade\u4e89\u683c\u5c40\uff1a\u793c\u6765\u7684\u5d1b\u8d77<\/h2>\n\n<p>\u5bf9\u8bfa\u548c\u8bfa\u5fb7\u9738\u4e3b\u5730\u4f4d\u6700\u91cd\u5927\u7684\u6311\u6218\u662f\u793c\u6765\u516c\u53f8 (NYSE: LLY) \u7684\u8fc5\u901f\u5d1b\u8d77\u3002\u793c\u6765\u57fa\u4e8e\u66ff\u5c14\u6cca\u80bd (tirzepatide) \u7684\u836f\u7269\u2014\u2014\u7528\u4e8e 2 \u578b\u7cd6\u5c3f\u75c5\u7684 Mounjaro \u548c\u7528\u4e8e\u80a5\u80d6\u75c7\u7684 Zepbound\u2014\u2014\u81ea\u63a8\u51fa\u4ee5\u6765\u8fc5\u901f\u62a2\u5360\u4e86\u5e02\u573a\u4efd\u989d\u3002\u5230 2026 \u5e74\u521d\uff0c\u793c\u6765\u5df2\u5360\u636e\u7f8e\u56fd GLP-1 \u5e02\u573a\u7ea6 60% \u7684\u4efd\u989d\uff0c\u53d6\u4ee3\u4e86\u8bfa\u548c\u8bfa\u5fb7\u6b64\u524d\u7684\u9886\u5148\u5730\u4f4d [4]\u3002  <\/p>\n\n<p>\u793c\u6765\u7684\u6210\u529f\u4e3b\u8981\u5f52\u529f\u4e8e\u66ff\u5c14\u6cca\u80bd\u5353\u8d8a\u7684\u4e34\u5e8a\u7597\u6548\u3002\u5728\u4e00\u9879\u5173\u952e\u7684\u5934\u5bf9\u5934\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\uff0c\u670d\u7528 Zepbound \u7684\u60a3\u8005\u4e0e\u670d\u7528\u8bfa\u548c\u8bfa\u5fb7 Wegovy \u7684\u60a3\u8005\u76f8\u6bd4\uff0c\u51cf\u91cd\u6548\u679c\u663e\u8457\u66f4\u4f73 [4]\u3002\u8fd9\u79cd\u4e34\u5e8a\u4f18\u52bf\u63a8\u52a8\u4e86\u533b\u751f\u7684\u9ad8\u5ea6\u504f\u597d\u548c\u60a3\u8005\u7684\u9700\u6c42\u3002\u4e24\u5bb6\u516c\u53f8\u53d1\u5c55\u8f68\u8ff9\u7684\u5206\u6b67\u5728\u5404\u81ea\u7684 2026 \u5e74\u5c55\u671b\u4e2d\u5f97\u5230\u4e86\u9c9c\u660e\u4f53\u73b0\uff1a\u8bfa\u548c\u8bfa\u5fb7\u9884\u8ba1\u9500\u552e\u989d\u5c06\u4e0b\u964d\uff0c\u800c\u793c\u6765\u5219\u9884\u6d4b\u6536\u5165\u5c06\u5b9e\u73b0 20% \u81f3 25% \u7684\u5f3a\u52b2\u589e\u957f\uff0c\u76ee\u6807\u603b\u6536\u5165\u8d85\u8fc7 800 \u4ebf\u7f8e\u5143 [4]\u3002   <\/p>\n\n<p>\u9664\u4e86\u7ade\u4e89\u538b\u529b\u5916\uff0c\u8bfa\u548c\u8bfa\u5fb7\u6700\u8fd1\u8fd8\u906d\u9047\u4e86\u91cd\u5927\u7684\u7814\u53d1\u7ba1\u7ebf\u632b\u6298\u3002\u5728\u4e00\u9879 3 \u671f\u5934\u5bf9\u5934\u8bd5\u9a8c\u4e2d\uff0c\u8bfa\u548c\u8bfa\u5fb7\u7684\u4e0b\u4e00\u4ee3\u80a5\u80d6\u75c7\u7ec4\u5408\u836f\u7269 CagriSema \u672a\u80fd\u8bc1\u660e\u5176\u5bf9\u793c\u6765 Zepbound \u7684\u975e\u52a3\u6548\u6027\uff0c\u5176\u51cf\u91cd\u6548\u679c\u4e3a 20%\uff0c\u800c Zepbound \u4e3a 24% [5]\u3002\u8fd9\u4e00\u7ed3\u679c\u4e25\u91cd\u6253\u51fb\u4e86\u6295\u8d44\u8005\u5bf9\u8bfa\u548c\u8bfa\u5fb7\u8fc5\u901f\u593a\u56de\u6ce8\u5c04\u5242\u5e02\u573a\u4e34\u5e8a\u4f18\u52bf\u80fd\u529b\u7684\u4fe1\u5fc3\u3002  <\/p>\n\n<h2 class=\"wp-block-heading\">\u8d22\u52a1\u8868\u73b0\u4e0e 2026 \u5e74\u7684\u963b\u529b<\/h2>\n\n<p>\u5c3d\u7ba1\u9762\u4e34\u65b0\u5174\u6311\u6218\uff0c\u8bfa\u548c\u8bfa\u5fb7\u5728 2025 \u5168\u5e74\u4ecd\u53d6\u5f97\u4e86\u5f3a\u52b2\u7684\u8d22\u52a1\u4e1a\u7ee9\u3002\u8be5\u516c\u53f8\u62a5\u544a\u603b\u6536\u5165\u4e3a 3,091 \u4ebf\u4e39\u9ea6\u514b\u6717\uff0c\u6309\u56fa\u5b9a\u6c47\u7387 (CER) \u8ba1\u7b97\u6bd4 2024 \u5e74\u589e\u957f\u4e86 10% [3]\u3002\u8425\u4e1a\u5229\u6da6\u6309\u56fa\u5b9a\u6c47\u7387\u8ba1\u7b97\u589e\u957f 6%\uff0c\u8fbe\u5230 1,277 \u4ebf\u4e39\u9ea6\u514b\u6717\uff0c\u800c\u51c0\u5229\u6da6\u8fbe\u5230 1,024 \u4ebf\u4e39\u9ea6\u514b\u6717 [3]\u3002\u80a5\u80d6\u75c7\u62a4\u7406\u4e1a\u52a1\u662f\u4e3b\u8981\u7684\u589e\u957f\u5f15\u64ce\uff0c\u5728 Wegovy \u5f3a\u52b2\u9700\u6c42\u7684\u63a8\u52a8\u4e0b\uff0c\u6309\u56fa\u5b9a\u6c47\u7387\u8ba1\u7b97\u98d9\u5347 31%\uff0c\u8fbe\u5230 823 \u4ebf\u4e39\u9ea6\u514b\u6717 [3]\u3002   <\/p>\n\n<p>\u8be5\u516c\u53f8\u4fdd\u6301\u7740\u5353\u8d8a\u7684\u76c8\u5229\u6307\u6807\uff0c\u6bdb\u5229\u7387\u4e3a 81.0%\uff0c\u8425\u4e1a\u5229\u6da6\u7387\u4e3a 41.3%\uff0c\u51c0\u8d44\u4ea7\u6536\u76ca\u7387 (ROE) \u8fbe\u5230\u60ca\u4eba\u7684 61.1% [4]\u3002\u8fd9\u4e9b\u6570\u636e\u51f8\u663e\u4e86\u8bfa\u548c\u8bfa\u5fb7\u6838\u5fc3\u4e1a\u52a1\u6a21\u5f0f\u7684\u5185\u5728\u5b9e\u529b\u3002 <\/p>\n\n<p>\u7136\u800c\uff0c\u5e02\u573a\u7684\u7126\u70b9\u5df2\u7a81\u7136\u8f6c\u5411\u8be5\u516c\u53f8\u7684 2026 \u5e74\u4e1a\u7ee9\u6307\u5f15\u3002\u8bfa\u548c\u8bfa\u5fb7\u9884\u8ba1 2026 \u5e74\u6309\u56fa\u5b9a\u6c47\u7387\u8ba1\u7b97\u7684\u8c03\u6574\u540e\u9500\u552e\u989d\u5c06\u4e0b\u964d 5% \u81f3 13%\uff0c\u8fd9\u4ee4\u6295\u8d44\u8005\u611f\u5230\u9707\u60ca [3]\u3002\u8fd9\u79cd\u4ece\u591a\u5e74\u4e24\u4f4d\u6570\u589e\u957f\u5230\u4e0b\u6ed1\u7684\u5267\u70c8\u9006\u8f6c\u662f\u7531\u591a\u79cd\u8d1f\u9762\u56e0\u7d20\u4ea4\u7ec7\u9a71\u52a8\u7684\uff1a  <\/p>\n\n<ol class=\"wp-block-list\">\n<li><strong>\u4ef7\u683c\u538b\u529b\uff1a<\/strong>\u7f8e\u56fd\u5e02\u573a\u6b63\u7ecf\u5386\u4e25\u91cd\u7684\u4ef7\u683c\u538b\u7f29\u3002\u6839\u636e\u300a\u901a\u80c0\u524a\u51cf\u6cd5\u6848\u300b(IRA)\uff0c\u8054\u90a6\u533b\u7597\u4fdd\u9669 (Medicare) \u8c08\u5224\u8fbe\u6210\u4e86 Ozempic\u3001Wegovy \u548c Rybelsus \u7684 71% \u5de8\u989d\u6298\u6263\uff0c\u5c06\u6bcf\u6708\u6210\u672c\u4ece 959 \u7f8e\u5143\u964d\u81f3 274 \u7f8e\u5143 [6]\u3002\u4e0e\u6b64\u540c\u65f6\uff0c\u8bfa\u548c\u8bfa\u5fb7\u5ba3\u5e03\u4ece 2027 \u5e74\u521d\u8d77\uff0c\u81ea\u613f\u5c06 Wegovy \u5728\u7f8e\u56fd\u7684\u6807\u4ef7\u964d\u4f4e\u591a\u8fbe 50%\uff0cOzempic \u964d\u4f4e 35% [7]\u3002  <\/li>\n\n\n\n<li><strong>\u8fd4\u5229\u51b2\u56de\uff1a<\/strong>2025 \u5e74\u7684\u8d22\u52a1\u4e1a\u7ee9\u56e0 42 \u4ebf\u7f8e\u5143\u7684\u7f8e\u56fd 340B \u8fd4\u5229\u51c6\u5907\u91d1\u51b2\u56de\u800c\u4eba\u4e3a\u63d0\u632f\uff0c\u8fd9\u662f\u4e00\u9879\u4e0d\u4f1a\u5728 2026 \u5e74\u91cd\u590d\u53d1\u751f\u7684\u975e\u7ecf\u5e38\u6027\u6536\u76ca [4]\u3002<\/li>\n\n\n\n<li><strong>\u4e13\u5229\u5230\u671f\uff1a<\/strong>\u8bfa\u548c\u8bfa\u5fb7\u9762\u4e34\u53f8\u7f8e\u683c\u9c81\u80bd (semaglutide) \u4e13\u5229\u5728\u5305\u62ec\u5370\u5ea6\u548c\u4e2d\u56fd\u5728\u5185\u7684\u5173\u952e\u56fd\u9645\u5e02\u573a\u5373\u5c06\u5230\u671f\u7684\u6311\u6218\uff0c\u8fd9\u4e3a\u4f4e\u6210\u672c\u4eff\u5236\u751f\u7269\u7c7b\u4f3c\u836f\u94fa\u5e73\u4e86\u9053\u8def [4]\u3002<\/li>\n<\/ol>\n\n<h2 class=\"wp-block-heading\">\u7ba1\u7ebf\u524d\u666f\uff1a\u590d\u82cf\u4e4b\u8def<\/h2>\n\n<p>\u867d\u7136 2026 \u5e74\u4f3c\u4e4e\u662f\u4e00\u4e2a\u4f4e\u8c37\u5e74\uff0c\u4f46\u8bfa\u548c\u8bfa\u5fb7\u7684\u7ba1\u7406\u5c42\u6b63\u5728\u6267\u884c\u65e8\u5728\u786e\u4fdd\u957f\u671f\u589e\u957f\u7684\u6218\u7565\u8f6c\u578b\u3002\u8fd9\u4e00\u6218\u7565\u7684\u6838\u5fc3\u662f\u4ece\u6ce8\u5c04\u7597\u6cd5\u5411\u53e3\u670d\u836f\u7269\u7684\u8fc7\u6e21\u3002 <\/p>\n\n<p>2025 \u5e74\u5e95\uff0cFDA \u6279\u51c6\u4e86 Wegovy \u7684\u53e3\u670d\u5242\u578b\uff08\u53f8\u7f8e\u683c\u9c81\u80bd 25mg\uff09\uff0c\u6807\u5fd7\u7740\u9996\u6b3e\u7528\u4e8e\u51cf\u91cd\u7684\u53e3\u670d GLP-1 \u836f\u7269\u95ee\u4e16\uff0c\u5177\u6709\u91cc\u7a0b\u7891\u610f\u4e49 [8]\u3002\u65e9\u671f\u7684\u5546\u4e1a\u53cd\u54cd\u975e\u5e38\u70ed\u70c8\uff0c\u5728 2026 \u5e74 1 \u6708\u63a8\u51fa\u540e\u7684\u524d\u56db\u5468\u5185\uff0c\u7ea6\u6709 170,000 \u540d\u60a3\u8005\u91c7\u7528\u4e86\u8fd9\u79cd\u836f\u7247 [4]\u3002\u6bcf\u65e5\u670d\u7528\u836f\u7247\u7684\u4fbf\u5229\u6027\u6781\u5927\u5730\u6269\u5c55\u4e86\u6f5c\u5728\u5e02\u573a\u3002\u8bfa\u548c\u8bfa\u5fb7\u7684\u6218\u7565\u4f9d\u9760\u53e3\u670d Wegovy \u7684\u5de8\u5927\u9500\u91cf\u589e\u957f\u6765\u62b5\u6d88\u4e0d\u53ef\u907f\u514d\u7684\u5355\u4f4d\u4ef7\u683c\u4e0b\u964d\u3002   <\/p>\n\n<p>\u6b64\u5916\uff0c\u516c\u53f8\u7684\u7814\u53d1\u7ba1\u7ebf\u6781\u5177\u524d\u666f\u3002\u6700\u53d7\u671f\u5f85\u7684\u8d44\u4ea7\u662f amycretin (zenagamtide)\uff0c\u8fd9\u662f\u4e00\u79cd\u4e0b\u4e00\u4ee3 GLP-1 \u548c\u80f0\u6dc0\u7d20 (amylin) \u53cc\u91cd\u6fc0\u52a8\u5242\u3002\u5728 2 \u671f\u8bd5\u9a8c\u4e2d\uff0c\u76ae\u4e0b\u6ce8\u5c04 amycretin \u5728 36 \u5468\u5185\u8868\u73b0\u51fa\u4ee4\u4eba\u5370\u8c61\u6df1\u523b\u7684 24% \u51cf\u91cd\u6548\u679c [9]\u3002\u8bfa\u548c\u8bfa\u5fb7\u6b63\u8ba1\u5212\u5728 2026 \u5e74\u5c06 amycretin \u7684\u76ae\u4e0b\u6ce8\u5c04\u548c\u53e3\u670d\u5242\u578b\u5747\u63a8\u8fdb\u81f3 3 \u671f\u8bd5\u9a8c\uff0c\u65e8\u5728\u76f4\u63a5\u6311\u6218\u793c\u6765\u7684\u7597\u6548\u4e3b\u5bfc\u5730\u4f4d [9]\u3002   <\/p>\n\n<h2 class=\"wp-block-heading\">\u4f30\u503c\u4e0e\u6295\u8d44\u903b\u8f91<\/h2>\n\n<p>\u5e02\u573a\u5bf9 2026 \u5e74\u4e1a\u7ee9\u6307\u5f15\u7684\u5267\u70c8\u53cd\u5e94\u6781\u5927\u5730\u6539\u53d8\u4e86\u8bfa\u548c\u8bfa\u5fb7\u7684\u4f30\u503c\u9762\u8c8c\u30022026 \u5e74 4 \u6708\uff0c\u8be5\u80a1\u7684\u6eda\u52a8\u5e02\u76c8\u7387 (P\/E) \u7ea6\u4e3a 10 \u500d\u81f3 11.5 \u500d\uff0c\u4e0e\u5386\u53f2\u4e94\u5e74\u5e73\u5747\u5e02\u76c8\u7387\uff08\u7ea6 22 \u500d\uff09\u76f8\u6bd4\uff0c\u5176\u4f30\u503c\u5927\u5e45\u6298\u4ef7 [4]\u3002\u8fd9\u79cd\u4f4e\u8ff7\u7684\u500d\u6570\u8868\u660e\uff0c\u5e02\u573a\u5df2\u6fc0\u8fdb\u5730\u6d88\u5316\u4e86\u9500\u552e\u989d\u957f\u671f\u4e0b\u964d\u7684\u6700\u574f\u60c5\u51b5\u3002  <\/p>\n\n<p><strong>\u770b\u7a7a\u89c2\u70b9\uff1a<\/strong><\/p>\n\n<p>\u60b2\u89c2\u4e3b\u4e49\u8005\u8ba4\u4e3a\uff0c\u8bfa\u548c\u8bfa\u5fb7\u7684\u7ed3\u6784\u6027\u4f18\u52bf\u5df2\u53d7\u5230\u6c38\u4e45\u6027\u635f\u5bb3\u3002\u793c\u6765\u66ff\u5c14\u6cca\u80bd\u7684\u4e34\u5e8a\u4f18\u8d8a\u6027\uff0c\u52a0\u4e0a CagriSema \u7684\u5931\u8d25\uff0c\u4f7f\u5f97\u8bfa\u548c\u8bfa\u5fb7\u5728\u6ce8\u5c04\u5242\u9886\u57df\u65e0\u6cd5\u7acb\u5373\u5bf9 Zepbound \u505a\u51fa\u56de\u5e94\u3002\u8054\u90a6\u533b\u7597\u4fdd\u9669\u4ef7\u683c\u8c08\u5224\u3001\u81ea\u613f\u6807\u4ef7\u524a\u51cf\u4ee5\u53ca\u65b0\u5174\u5e02\u573a\u5373\u5c06\u5230\u6765\u7684\u4e13\u5229\u60ac\u5d16\u7b49\u591a\u91cd\u538b\u529b\u5c06\u4e25\u91cd\u538b\u7f29\u5229\u6da6\u7387\u3002\u5728\u8fd9\u79cd\u89c2\u70b9\u4e0b\uff0c\u8bfa\u548c\u8bfa\u5fb7\u6b63\u4ece\u9ad8\u589e\u957f\u7684\u5784\u65ad\u8005\u8f6c\u53d8\u4e3a\u5546\u54c1\u5316\u53cc\u5934\u5784\u65ad\u683c\u5c40\u4e2d\u7684\u6210\u719f\u53c2\u4e0e\u8005\u3002   <\/p>\n\n<p><strong>\u770b\u591a\u89c2\u70b9\uff1a<\/strong><\/p>\n\n<p>\u4e50\u89c2\u4e3b\u4e49\u8005\u8ba4\u4e3a\uff0c\u5f53\u524d\u7684\u4f30\u503c\u662f\u8fdb\u5165\u8fd9\u4e00\u57fa\u672c\u9762\u7a33\u5065\u4e1a\u52a1\u7684\u6781\u5177\u5438\u5f15\u529b\u7684\u5207\u5165\u70b9\u30022026 \u5e74\u7684\u4e1a\u7ee9\u6307\u5f15\u4ee3\u8868\u7684\u662f\u6682\u65f6\u7684\u201c\u9884\u671f\u5dee\u201d\uff0c\u800c\u975e\u7ec8\u7ed3\u6027\u7684\u8870\u9000\u3002\u53e3\u670d Wegovy \u7684\u8fc5\u901f\u666e\u53ca\u8bc1\u660e\u4e86\u5de8\u5927\u7684\u6f5c\u5728\u9700\u6c42\uff0c\u8fd9\u53ef\u4ee5\u63a8\u52a8\u53ef\u89c2\u7684\u9500\u91cf\u589e\u957f\u3002\u6b64\u5916\uff0camycretin \u7ba1\u7ebf\u8d44\u4ea7\u63d0\u4f9b\u4e86\u4e00\u6761\u91cd\u8fd4\u4e34\u5e8a\u5bf9\u7b49\u6216\u9886\u5148\u5730\u4f4d\u7684\u53ef\u9760\u8def\u5f84\u3002\u51ed\u501f\u7a33\u5065\u7684\u8d44\u4ea7\u8d1f\u503a\u8868\u3001\u5353\u8d8a\u7684\u8d44\u672c\u56de\u62a5\u7387 (ROIC) \u548c 3.8% \u7684\u80a1\u606f\u7387\uff0c\u8bfa\u548c\u8bfa\u5fb7\u5177\u5907\u5e94\u5bf9\u5f53\u524d\u52a8\u8361\u7684\u8d22\u52a1\u97e7\u6027\u3002    <\/p>\n\n<h2 class=\"wp-block-heading\">\u7ed3\u8bba<\/h2>\n\n<p>\u8bfa\u548c\u8bfa\u5fb7\u6b63\u5904\u4e8e\u5176\u8fd1\u671f\u5386\u53f2\u4e0a\u6700\u5177\u6311\u6218\u6027\u7684\u65f6\u671f\u3002\u4ece\u65e0\u7ea6\u675f\u5b9a\u4ef7\u548c\u7c7b\u5784\u65ad\u4e3b\u5bfc\u5730\u4f4d\u7684\u65f6\u4ee3\uff0c\u5411\u9ad8\u5ea6\u7ade\u4e89\u3001\u4ef7\u683c\u654f\u611f\u7684\u73af\u5883\u8fc7\u6e21\uff0c\u9700\u8981\u8270\u96be\u7684\u6218\u7565\u8c03\u6574\u3002\u867d\u7136 2026 \u5e74\u65e0\u7591\u5c06\u662f\u4e00\u4e2a\u4ee5\u6536\u5165\u6536\u7f29\u4e3a\u7279\u5f81\u7684\u75db\u82e6\u8f6c\u578b\u5e74\uff0c\u4f46\u516c\u53f8\u5411\u53e3\u670d\u7597\u6cd5\u7684\u79ef\u6781\u8f6c\u578b\u53ca\u5176\u5145\u6ee1\u5e0c\u671b\u7684\u4e0b\u4e00\u4ee3\u7ba1\u7ebf\u4e3a\u590d\u82cf\u63d0\u4f9b\u4e86\u53ef\u884c\u7684\u8def\u7ebf\u56fe\u3002\u5bf9\u4e8e\u613f\u610f\u5fcd\u53d7\u77ed\u671f\u6ce2\u52a8\u7684\u957f\u671f\u6295\u8d44\u8005\u800c\u8a00\uff0c\u5f53\u524d\u4f4e\u8ff7\u7684\u4f30\u503c\u53ef\u80fd\u63d0\u4f9b\u4e86\u4e00\u4e2a\u4ee5\u5927\u5e45\u6298\u6263\u6536\u8d2d\u4f18\u8d28\u533b\u836f\u8d44\u4ea7\u7684\u8bf1\u4eba\u673a\u4f1a\u3002   <\/p>\n\n<h2 class=\"wp-block-heading\">\u53c2\u8003\u6587\u732e<\/h2>\n\n<p>[1] GlobeNewswire. &#8220;GLP-1 Agonists Market &#8211; Global Forecast to 2033.&#8221; 2025 \u5e74 12 \u6708 23 \u65e5\u3002  <\/p>\n\n<p>[2] \u6469\u6839\u5927\u901a. &#8220;How Supply and Demand for Weight Loss Drugs is Playing Out in 2026.&#8221; 2026 \u5e74 2 \u6708\u3002  <\/p>\n\n<p>[3] \u8bfa\u548c\u8bfa\u5fb7 A\/S. &#8220;Annual Report 2025 &#8211; Financial Performance.&#8221; 2026 \u5e74\u3002 <\/p>\n\n<p>[4] Kavout. &#8220;Why Did Novo Nordisk Stock Plummet Recently.&#8221; 2026 \u5e74 4 \u6708\u3002  <\/p>\n\n<p>[5] BioPharma Dive. &#8220;Novo&#8217;s next-gen obesity shot fails to match Lilly drug in head-to-head trial.&#8221; 2026 \u5e74 2 \u6708 23 \u65e5\u3002  <\/p>\n\n<p>[6] NPR. &#8220;Medicare negotiated lower prices for 15 drugs.&#8221; 2025 \u5e74 11 \u6708 26 \u65e5\u3002  <\/p>\n\n<p>[7] CNBC. &#8220;Novo Nordisk to slash Wegovy, Ozempic U.S. list prices by up to 50%.&#8221; 2026 \u5e74 2 \u6708 24 \u65e5\u3002  <\/p>\n\n<p>[8] PR Newswire. &#8220;FDA approves Novo Nordisk&#8217;s Wegovy pill.&#8221; 2025 \u5e74 12 \u6708 22 \u65e5\u3002  <\/p>\n\n<p>[9] FierceBiotech. &#8220;Novo Nordisk plots phase 3 trials for next-gen obesity asset amycretin.&#8221; 2025 \u5e74 6 \u6708\u3002  <\/p>\n\n<p><em>\u672c\u6587\u4ec5\u4f9b\u53c2\u8003\u548c\u6559\u80b2\u76ee\u7684\uff0c\u4e0d\u6784\u6210\u8d22\u52a1\u3001\u6295\u8d44\u6216\u4ea4\u6613\u5efa\u8bae\u3002EquitiesOrbis.com \u53ca\u5176\u64b0\u7a3f\u4eba\u5bf9\u56e0\u4f9d\u8d56\u6240\u5448\u73b0\u7684\u4fe1\u606f\u800c\u9020\u6210\u7684\u4efb\u4f55\u8d22\u52a1\u635f\u5931\u6216\u635f\u5bb3\u4e0d\u627f\u62c5\u8d23\u4efb\u3002\u5f3a\u70c8\u5efa\u8bae\u8bfb\u8005\u5728\u505a\u51fa\u4efb\u4f55\u6295\u8d44\u51b3\u5b9a\u4e4b\u524d\uff0c\u8fdb\u884c\u72ec\u7acb\u7684\u5c3d\u804c\u8c03\u67e5\uff0c\u54a8\u8be2\u5408\u683c\u7684\u8d22\u52a1\u987e\u95ee\uff0c\u5e76\u4ed4\u7ec6\u8003\u8651\u81ea\u5df1\u7684\u98ce\u9669\u627f\u53d7\u80fd\u529b\u3002\u8fc7\u5f80\u4e1a\u7ee9\u5e76\u4e0d\u4ee3\u8868\u672a\u6765\u7ed3\u679c\uff0c\u6295\u8d44\u4ef7\u503c\u53ef\u80fd\u4f1a\u5927\u5e45\u6ce2\u52a8\u3002   <\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u8bfa\u548c\u8bfa\u5fb7 (NYSE: NVO) \u662f\u50ac\u5316&hellip;<\/p>\n","protected":false},"author":3,"featured_media":548,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"class_list":["post-689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-48"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3 - Equities Orbis<\/title>\n<meta name=\"description\" content=\"Global equity research and stock analysis. Valuations, catalysts, and investment theses \u2014 stocks of the world, revealed.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3 - Equities Orbis\" \/>\n<meta property=\"og:description\" content=\"Global equity research and stock analysis. Valuations, catalysts, and investment theses \u2014 stocks of the world, revealed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/\" \/>\n<meta property=\"og:site_name\" content=\"Equities Orbis\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-27T11:11:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-08T19:09:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-27_13-03-20.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"864\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ralph Sun\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ralph Sun\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/\"},\"author\":{\"name\":\"Ralph Sun\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/#\\\/schema\\\/person\\\/a9108a093682234f34f128b11fc8346c\"},\"headline\":\"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3\",\"datePublished\":\"2026-04-27T11:11:32+00:00\",\"dateModified\":\"2026-06-08T19:09:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/\"},\"wordCount\":148,\"publisher\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/equitiesorbis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/photo_2026-04-27_13-03-20.jpg\",\"articleSection\":[\"\u751f\u7269\u6280\u672f\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/\",\"url\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/\",\"name\":\"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3 - Equities Orbis\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/equitiesorbis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/photo_2026-04-27_13-03-20.jpg\",\"datePublished\":\"2026-04-27T11:11:32+00:00\",\"dateModified\":\"2026-06-08T19:09:41+00:00\",\"description\":\"Global equity research and stock analysis. Valuations, catalysts, and investment theses \u2014 stocks of the world, revealed.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/equitiesorbis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/photo_2026-04-27_13-03-20.jpg\",\"contentUrl\":\"https:\\\/\\\/equitiesorbis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/photo_2026-04-27_13-03-20.jpg\",\"width\":1536,\"height\":864},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/#website\",\"url\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/\",\"name\":\"Equities Orbis\",\"description\":\"Stocks of the World, Revealed.\",\"publisher\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/#organization\",\"name\":\"OT Media Inc.\",\"url\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/equitiesorbis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/photo_2026-04-24_10-17-06.jpg\",\"contentUrl\":\"https:\\\/\\\/equitiesorbis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/photo_2026-04-24_10-17-06.jpg\",\"width\":64,\"height\":64,\"caption\":\"OT Media Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/#\\\/schema\\\/person\\\/a9108a093682234f34f128b11fc8346c\",\"name\":\"Ralph Sun\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/equitiesorbis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/avatar_user_3_1777114349-96x96.jpg\",\"url\":\"https:\\\/\\\/equitiesorbis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/avatar_user_3_1777114349-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/equitiesorbis.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/avatar_user_3_1777114349-96x96.jpg\",\"caption\":\"Ralph Sun\"},\"description\":\"Ralph Sun is a media executive with a diverse background spanning technology, finance, and media. He is currently the CEO of OT Media Inc. His experience includes roles such as Communications Consultant at SCRT Labs, Editor at Cointelegraph, Public Relations Manager at IoTeX, and Advisor at Bitget. He has also worked as a Financial Writer for The Motley Fool and a Biotech Contributor for Seeking Alpha.\",\"url\":\"https:\\\/\\\/equitiesorbis.com\\\/zh-hans\\\/author\\\/ralph-sun\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3 - Equities Orbis","description":"Global equity research and stock analysis. Valuations, catalysts, and investment theses \u2014 stocks of the world, revealed.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/","og_locale":"zh_CN","og_type":"article","og_title":"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3 - Equities Orbis","og_description":"Global equity research and stock analysis. Valuations, catalysts, and investment theses \u2014 stocks of the world, revealed.","og_url":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/","og_site_name":"Equities Orbis","article_published_time":"2026-04-27T11:11:32+00:00","article_modified_time":"2026-06-08T19:09:41+00:00","og_image":[{"width":1536,"height":864,"url":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-27_13-03-20.jpg","type":"image\/jpeg"}],"author":"Ralph Sun","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Ralph Sun","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/#article","isPartOf":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/"},"author":{"name":"Ralph Sun","@id":"https:\/\/equitiesorbis.com\/zh-hans\/#\/schema\/person\/a9108a093682234f34f128b11fc8346c"},"headline":"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3","datePublished":"2026-04-27T11:11:32+00:00","dateModified":"2026-06-08T19:09:41+00:00","mainEntityOfPage":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/"},"wordCount":148,"publisher":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/#organization"},"image":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/#primaryimage"},"thumbnailUrl":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-27_13-03-20.jpg","articleSection":["\u751f\u7269\u6280\u672f"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/","url":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/","name":"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3 - Equities Orbis","isPartOf":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/#website"},"primaryImageOfPage":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/#primaryimage"},"image":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/#primaryimage"},"thumbnailUrl":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-27_13-03-20.jpg","datePublished":"2026-04-27T11:11:32+00:00","dateModified":"2026-06-08T19:09:41+00:00","description":"Global equity research and stock analysis. Valuations, catalysts, and investment theses \u2014 stocks of the world, revealed.","breadcrumb":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/#primaryimage","url":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-27_13-03-20.jpg","contentUrl":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-27_13-03-20.jpg","width":1536,"height":864},{"@type":"BreadcrumbList","@id":"https:\/\/equitiesorbis.com\/zh-hans\/%e8%af%ba%e5%92%8c%e8%af%ba%e5%be%b7-nvo%ef%bc%9a%e9%a2%86%e8%88%aa-glp-1-%e9%9d%a9%e5%91%bd%e7%9a%84%e6%96%b0%e6%97%b6%e4%bb%a3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/equitiesorbis.com\/zh-hans\/"},{"@type":"ListItem","position":2,"name":"\u8bfa\u548c\u8bfa\u5fb7 (NVO)\uff1a\u9886\u822a GLP-1 \u9769\u547d\u7684\u65b0\u65f6\u4ee3"}]},{"@type":"WebSite","@id":"https:\/\/equitiesorbis.com\/zh-hans\/#website","url":"https:\/\/equitiesorbis.com\/zh-hans\/","name":"Equities Orbis","description":"Stocks of the World, Revealed.","publisher":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/equitiesorbis.com\/zh-hans\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/equitiesorbis.com\/zh-hans\/#organization","name":"OT Media Inc.","url":"https:\/\/equitiesorbis.com\/zh-hans\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/equitiesorbis.com\/zh-hans\/#\/schema\/logo\/image\/","url":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-24_10-17-06.jpg","contentUrl":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-24_10-17-06.jpg","width":64,"height":64,"caption":"OT Media Inc."},"image":{"@id":"https:\/\/equitiesorbis.com\/zh-hans\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/equitiesorbis.com\/zh-hans\/#\/schema\/person\/a9108a093682234f34f128b11fc8346c","name":"Ralph Sun","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/avatar_user_3_1777114349-96x96.jpg","url":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/avatar_user_3_1777114349-96x96.jpg","contentUrl":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/avatar_user_3_1777114349-96x96.jpg","caption":"Ralph Sun"},"description":"Ralph Sun is a media executive with a diverse background spanning technology, finance, and media. He is currently the CEO of OT Media Inc. His experience includes roles such as Communications Consultant at SCRT Labs, Editor at Cointelegraph, Public Relations Manager at IoTeX, and Advisor at Bitget. He has also worked as a Financial Writer for The Motley Fool and a Biotech Contributor for Seeking Alpha.","url":"https:\/\/equitiesorbis.com\/zh-hans\/author\/ralph-sun\/"}]}},"featured_image_src":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-27_13-03-20-600x400.jpg","featured_image_src_square":"https:\/\/equitiesorbis.com\/wp-content\/uploads\/2026\/04\/photo_2026-04-27_13-03-20-600x600.jpg","author_info":{"display_name":"Ralph Sun","author_link":"https:\/\/equitiesorbis.com\/zh-hans\/author\/ralph-sun\/"},"_links":{"self":[{"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/posts\/689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=689"}],"version-history":[{"count":0,"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/posts\/689\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/media\/548"}],"wp:attachment":[{"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/equitiesorbis.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}